Key Learning Objectives
- Understand why the patient-site relationship is pivotal in any clinical trial.
- Recognize the most promising areas where technologies such as eConsent, eCOA/ePRO, and event-driven eDiaries positively impact clinical trials for patient, sites, and sponsors.
- Recognize the industry must ensure AI is used to create positive impacts on clinical research and patient health and well-being.
Empathy-driven technology can reduce participant burden and improve trial compliance by strengthening the bond between investigators and patients. Steve Rosenberg, CEO of uMotif, details how the company’s modern, scalable platform supports patient-reported outcomes and efficient site management, which led to the company being named a major contender in the 2025 Everest Group eCOA products assessment. Discover how digital companions and flexible technology are reshaping the future of clinical research to better serve an evolving patient population.
